Premium
Treatment of Cutaneous Infections Worldwide Experience with Ciprofloxacin
Author(s) -
Parish Lawrence Charles,
Witkowski Joseph A.,
Junckind Donald L.,
Asper Ronald F.
Publication year - 1988
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1988.tb01295.x
Subject(s) - medicine , ciprofloxacin , dermatology , anti infective agents , intensive care medicine , antibiotics , microbiology and biotechnology , antimicrobial , biology
Oral ciprofloxacin, a new fluorinated 4‐quino‐lone, was evaluated in 795 patients with skin and skin structure infections. Ninety‐four point one percent of the patients treated had clinical success with eradication of almost all of the offending bacteria. Ciprofloxacin has good activity against gram‐positive organisms and excellent activity against gram‐negative organisms. Side effects were few and not considered significant.